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Abstract
Background: The pathogenesis of severe acute respiratory disease syndrome (SARS) is not fully
understood. One case-control study has reported an association between susceptibility to SARS
and mannan-binding lectin (MBL) in China. As the downstream protein of MBL, variants of the MBL-
associated serine protease-2 (MASP2) gene may be associated with SARS coronavirus (SARS-CoV)
infection in the same population.
Methods: Thirty individuals with SARS were chosen for analysis of MASP2 polymorphisms by
means of PCR direct sequencing. Tag single nucleotide polymorphisms (tagSNPs) were chosen
using pairwise tagging algorithms. The frequencies of four tag SNPs (rs12711521, rs2261695,
rs2273346 and rs7548659) were ascertained in 376 SARS patients and 523 control subjects, using
the Beckman SNPstream Ultra High Throughput genotyping platform.
Results: There is no significant association between alleles or genotypes of the MASP2 tagSNP and
susceptibility to SARS-CoV in both Beijing and Guangzhou populations. Diplotype (rs2273346 and
rs12711521)were analyzed for association with susceptibility to SARS, no statistically significant
evidence of association was observed. The Beijing and Guangzhou sample groups were
homogeneous regarding demographic and genetic parameters, a joined analysis also showed no
statistically significant evidence of association.
Conclusion: Our data do not suggest a role for MASP2 polymorphisms in SARS susceptibility in
northern and southern China.
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Background
Severe acute respiratory disease syndrome (SARS), a new
and highly infectious disease that is caused by a previously
undescribed coronavirus in humans, has created a major
public health threat in many countries [1-3]. Progress has
been made in understanding SARS coronavirus (SARS-
CoV) and the epidemiology, clinical manifestations, lab-
oratory findings and radiological features of this disease
have all been studied in detail [4,5]. However, its patho-
genesis is still not fully understood. It has been reported
that diabetes mellitus and heart disease are risk factors for
adverse prognosis of SARS [6], however, little is known
about the contribution of genetic factors.
SARS has been found to have a profoundly adverse effect
on the immune system [7]. Variation in host immunity
may be one of the important factors that determine sus-
ceptibility to SARS. A few case-control studies have
reported an association between SARS susceptibility and
human leucocyte antigen (HLA) and MBL [8-11]. Defi-
ciency of MBL, a key component of the innate immune
system, has been detected in SARS patients. Such a defi-
ciency may increase susceptibility to SARS infection. Three
papers reported the association of HLA and susceptibility
to SARS [8-10]. Of these, two reported the association of
HLA with susceptibility and resistance to the development
of SARS [8,9]. In a more recent paper, no statistical signif-
icance was found with the susceptibility and severity of
the disease [10].
MBL is a member of the collectin family and plays an
important role in innate immunity [12,13]. MBL and fico-
lins distinguish between self, non-self and altered-self by
recognizing patterns of ligands on the surface of microor-
ganisms or aberrant cells. When this happens, MBL-asso-
ciated serine protease-2 (MASP-2) is activated and cleaves
complement factors to initiate the antibody-independent
pathway of the complement system, thus starting inflam-
matory reactions.
MBL-associated serine proteases interact with MBL via the
collagenous region of larger MBL oligomers. Four related
proteins derived from two genes have been reported;
namely  MASP1, its alternative splicing variant MASP3,
and MASP2  with its alternative splicing variant Map19
[14-16].  MASP2  activates the complement system by
cleaving complement proteins C4 and C2. MASP2 is an
essential component of the lectin pathway of complement
activation.
MASP2 deficiency is observed because of genetic polymor-
phisms. It is known that a MASP2 polymorphism, namely
D120G has a functional effect on the protein, and does
not allow the formation of an active MBL-MASP complex.
This variant has been described for the first time in a
patient with an inherited deficiency of MASP2, who was
characterized by augmented susceptibility to infection
and development of immunological disease.
With regard to SARS-CoV infection, the codon 54 variant
of the MBL gene has been shown to be associated with
infection susceptibility but not with disease severity [11].
As the downstream protein of MBL, variants of the MASP2
gene may be associated with SARS-CoV infection. To
examine the hypothesis that polymorphisms of the
MASP2 gene in SARS patients are genetic factors that influ-
ence infection susceptibility, we studied MASP2 gene pol-
ymorphisms in DNA from two groups of Chinese SARS
patients, and compared these with normal blood donors
from the same region.
Methods
Recruitment of subjects for case-control study
This study was performed with the approval of the Ethical
Committee of the Chinese Human Genome Center. A
total of 376 SARS patients, who were diagnosed based on
WHO criteria, were recruited during the 2003 outbreak.
All SARS patients selected for study were unrelated and
were shown to be seropositive by anti-SARS-N protein
ELISA and immunofluorecent assay (IFA). The specificity
of the ELISA assay is more than 99% [17,18]. Of these,
272 were from the wards at Xiaotangshan Hospital, Bei-
jing, China, and the remaining 104 were from the Eighth
People's Hospital of Guangzhou in southern China. A
total of 523 age, sex, and ethnicity-matched healthy,
genetically unrelated and seronegative (confirmed by
anti-SARS N protein antibody ELISA and SARS antibody
IFA) adults were recruited as control subjects. We
extracted genomic DNA from peripheral blood leukocytes
of affected individuals and controls using the QIAamp
DNA Mini Kit (Qiagen, Valencia, CA). DNA was quanti-
fied using standardized fluorometric reading on a DU 650
spectrophotometer (Beckman Coulter, Fullerton, CA).
Each sample was diluted to a final concentration of 10 ng/
ul.
Discovery of polymorphisms
Genomic DNA from 30 individuals with SARS was chosen
for analysis of MASP2 gene polymorphisms. The sample
included 60 chromosomes, which provided a 95% confi-
dence level to detect alleles with a frequency >5% [19].
With a candidate-gene strategy, we screened for polymor-
phisms in all exons (~2.0 kb), 5'- and 3'-flanking regions
(lengths of 2.5 kb), untranslated regions (~0.3 kb), and
about 2.5 kb intronic sequences. DNA sequence spanning
the MASP2 gene was obtained from the National Center
for Biotechnology Information (NCBI) website (available
from http://www.ncbi.nlm.nih.gov/; NT_021937.18).
Primers were designed using the Premier program (Primer
Premier 5). PCR primer sequences see Additional file 1.BMC Infectious Diseases 2009, 9:51 http://www.biomedcentral.com/1471-2334/9/51
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DNA samples from the 30 individuals were amplified and
purified. The PCR reaction volume was 50 μl, containing
10–50 ng of DNA,10 pmol of each forward and reverse
primer, 0.2 mmol/L of each dNTP,0.3 U of DNA polymer-
ase(Tiangen Biotec Co, Beijing, China),10 mmol/L of Tris-
HCl, 1.5 mmol/L of MgCl2, 50 mmol/L of KCl, and 0.1%
Triton X-100. Amplication was carried out in a GeneAmp
PCR system 9700(ABI) with cycle parameters of 5 min
94°C (initial denaturation), 32 rounds of 94°C 30 s, 54–
55°C 30 s, and 72°C 45 s, and a final extention for 5 min
at 72°C. PCR products were sequenced using an ABI
PRISM Dye Terminator Sequencing Kit with AmpliTaq
Gold DNA Polymerase (Applied Biosystems Division/Per-
kin-Elmer, Foster City, CA) and loaded onto an ABI 3100
sequencer. Polymorphism candidates were identified by
the PolyPhred program. (P. Green, personal communica-
tion) SNP genotypes were verified by manual evaluation
of the individual sequence traces.
Genotyping
Genotyping was completed using SNPstream Ultra High
Throughput genotyping system (Beckman Coulter, Fuller-
ton, CA) according to the manufacture's instructions.
Briefly, the method combines solution-phase multiplex
single nucleotide extension (SNE) with a solid-phase sort-
ing of labeled SNE primers by hybridization to a chip that
contains 384 4 × 4 arrays of 12 oligo-nucleotide tags and
4 oligo-nucleotides for positive and negative controls.
Each SNE primer contained 1 of the 20 oligonucleotide
tags at its 5' end, and the SNE reactions were performed in
12-plex. The microarray plate was imaged by the
SNPscope reader (Beckman Coulter, Fullerton, CA). The
two-color system allowed the detection of the SNP by
comparing signals from the two fluorescent dyes. The
image signals were then transferred to genotyping soft-
ware that translated the images of the arrays into genotype
calls. The error rate based upon sequencing for 10% of the
SNPs examined in the present study was 0–1.2%.
Statistical analysis
The Exact Test was calculated to evaluate if the population
was in Hardy-Weinberg equilibrium by the Markov chain
method, taking P < 0.05 as the cutoff for assessing signifi-
cance. The tagSNPs were chosen on a pairwise basis and
linkage disequilibrium (LD) calculation was performed
on the confidence interval basis using Haploview 3.2 soft-
ware.
Genotype and alleles frequencies for each polymorphism
were determined by gene counting. Diplotypes of each
individual were inferred using the algorithm developed by
Stephens et al. (2001) (PHASE). The chi square test was
used to determine whether allele frequencies differed
between SARS cases and controls. Binary logistic regres-
sion was used to analyze the association between a single
locus and SARS susceptibility, adjusted for sex and age sta-
tus, and odds ratio and 95% CI were used to measure
strength of association in a genetic risk association study.
These statistical analyses were implemented in Statistical
Package for the Social Sciences 13.0 software (SPSS Inc,
Chicago, Illinois, USA).
Results
Demographic characteristics of the population
Demographic characteristics are shown in Table 1. The age
and sex distribution of the patients and controls were not
significantly different, which indicated that the matching
of controls to cases was adequate.
Screening MASP2 for polymorphisms
Sequencing of the 11 exons of MASP2, the 5' and 3'
regions of the gene, and some intronic sequences in 30
individuals with SARS identified 17 polymorphisms
(Table 2). Eleven of the SNPs have been published in the
dbSNP database http://www.ncbi.nlm.nih.gov/SNP/
index.html. Allele and genotype frequencies were consist-
ent with those expected under Hardy-Weinberg equilib-
rium. Nine SNPs (allele frequency >5%) were chosen with
Haploview for assessment. The SNPs were contained in
two blocks of LD (Fig. 1), as defined by Lewontin's| D'|.
SNPs including rs7548659, rs2273347 and rs6695096
were located outside of the defined LD blocks. Four tag-
SNPs were chosen with the pairwise tagging algorithm
implemented in the Tagger program of Haploview:
rs7548659, rs12711521, rs2273346 and rs2261695 (r2
threshold was 0.8). Genotype frequencies of the tag-SNP
except rs2261695 in other populations that have been
published in the HapMap database were shown in table 3
Table 1: Demographic characteristics of SARS patients and 
controls
SARS patients Controls P
Beijing population (n = 272) (n = 232)
Sex
Male 119(43.8%) 117(50.4%) 0.13
Female 153(56.2%) 115(49.6%)
Age (years)
16–30 82(30.1%) 70(30.2%) 0.99
31–40 88(32.4%) 74(31.9%)
41–50 63(23.2%) 54(23.2%)
> 50 39(14.3%) 34(14.7%)
Guangzhou population (n = 104) (n = 291)
Sex
Male 46(44.2%) 150(51.5%) 0.20
Female 58(55.8%) 141(48.5%)
Age (years)
16–30 33(31.7%) 86(29.6%) 0.73
31–40 35(33.7%) 88(30.2%)
41–50 21(20.2%) 74(25.4%)
> 50 15(14.4%) 43(14.8%)BMC Infectious Diseases 2009, 9:51 http://www.biomedcentral.com/1471-2334/9/51
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as control. http://www.hapmap.org/cgi-perl/gbrowse/
hapmap3_B36/. The four TagSNPs were genotyped in
SARS patients and controls with an average success rate of
96%.
MASP2 polymorphisms and susceptibility to SARS-CoV
Genotype data and diplotype (rs2273346 and
rs12711521) were analyzed for association with suscepti-
bility to SARS, in Beijing and Guangzhou populations,
using Binary logistic regression for overall genotypic asso-
ciation (Tables 4 and 5). No statistically significant evi-
dence of association was observed. The Beijing and
Guangzhou sample groups were homogeneous regarding
demographic and genetic parameters, so a joined analysis
was done, No statistically significant evidence of associa-
tion was observed (Table 6).
Discussion
Possible contribution of host genetic factors to the suscep-
tibility and outcome of SARS-CoV infection has been
investigated through several association studies [20-23],
MBL deficiency because of polymorphisms in the MBL
gene has been shown to be involved in SARS-CoV infec-
tion. As the downstream protein of MBL, improper MASP
activity can interfere with complement functions [24].
there is an association between the genetics of MASP2 and
its serum level [24-27]. Thiel et al. [24] have analyzed the
mutation of p.156_159-dupCHNH and SNPs p.R99Q,
p.R118C, p.D120G, p.P126L and p.V377A in four popu-
Table 2: SNPs in MASP2
Region Nucleotidea dbSNP ID MAFb Coding polymorphism
5'Up-stream -153(A/C) rs7548659 0.230
intron4 3629(C/T) - 0.017
intron5 3934(C/T) rs3737612 0.017
intron6 9402(G/T) - 0.017
exon7 9420(A/G) rs12142107 0.017 Ala/Ala
intron7 9736(C/T) - 0.017
intron7 9740(G/T) - 0.017
intron7 12246(A/G) rs6695096 0.140
intron8 16254(C/T) rs9430176 0.190
exon9 16369(G/T) rs12711521 0.350 Tyr/Asp
exon9 16388(C/T) rs2273346 0.190 Ala/Val
exon11 19594(C/T) rs1782455 0.130 Ser/Ser
exon11 20009(A/C) - 0.017
exon11 20250(A/C) - 0.017
3'UTR 20564(C/T) rs1033638 0.138
3'Down-stream 20842(G/A) rs2261695 0.143
3'Down-stream 20949(T/C) rs2273347 0.340
aNumbering is from the A of the ATG. bMAF, minor allele frequency
Table 3: Genotype frequencies of the three tag-SNP in other populations
SNPa CEU(n = 59) HCB(n = 45) JPT(n = 44) YRI(n = 60)
rs2273346
Genotype
TT 100.0% 62.2% 70.5% 70.0%
TC 0.0% 28.9% 25.0% 28.3%
CC 0.0% 8.9% 4.5% 1.7%
rs12711521
Genotype
TT 71.7% 37.8% 48.9% 1.6%
TG 28.3% 42.2% 44.4% 16.7%
GG 0.0% 20.0% 6.7% 81.7%
rs7548659
Genotype
TT 65.0% 48.9% 65.9% 1.8%
TG 35.0% 42.2% 29.5% 14.0%
GG 0.0% 8.9% 4.5% 84.2%
a The genotype frequencies of rs2261695 were not shown in HapMap database.BMC Infectious Diseases 2009, 9:51 http://www.biomedcentral.com/1471-2334/9/51
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lations: Africans from Zambia, Hong Kong Chinese, Bra-
zilian Amerindians and Danish Caucasians. p.156_159-
dupCHNH was only found in Chinese (gene frequency
0.26%), associated with low levels of MASP2, and
p.D120G was found only in Caucasians. p.P126L and
p.R99Q were present in Africans and Amerindians only.
MASP2 levels were reduced in individuals with p.V377A
(rs2273346). Therefore, we chose 30 individuals with
SARS from Beijing for analysis of MASP2 gene polymor-
phisms. The sample included 60 chromosomes, which
provided a 95% confidence level to detect alleles with a
frequency >5%. However, we only observed the SNP
rs2273346 (p.V377A) among those mentioned in the
study of Thiel et al. We analyzed four tagSNPs in the
MASP2 gene in two different SARS patients and controls,
searching for a possible genotype-phenotype correction,
but no statistically significant difference was found for any
polymorphisms between the different groups genotyped,
while the possible role of the rare variants is to be deter-
mined.
Conclusion
Our analysis indicates that MASP2 polymorphisms is not
directly related to SARS-CoV susceptibility in northern
and southern Chinese.
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Gene content of NC_000001.9 in chromosome 1p36, discovered SNPs and LD of MASP2 Figure 1
Gene content of NC_000001.9in chromosome 1p36, discovered SNPs and LD of MASP2. (a) Genomic structure of 
genes in this region. (b) Exons of MASP2 and the position of SNPs discovered. (c) Pairwise LD between SNPs (MAF >0.05) at 
this gene. The value within each diamond represents the pairwise correction between SNPs (measured as D') defined by the 
upper left and upper right sides of the diamond. The diamond without a number corresponds to D' = 1. Shading represents the 
magnitude and significance of pairwise LD, with a red-to-white gradient reflecting higher to lower LD values.BMC Infectious Diseases 2009, 9:51 http://www.biomedcentral.com/1471-2334/9/51
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Table 4: Genotype and allele frequencies of tagSNPs in MASP2 in SARS patients and controls from Beijing, and their association with 
risk of SARS
SARS cases
(n = 272)
Controls
(n = 232)
P value
rs2261695
Genotype
AA 189 (70.3%) 174 (75.0%) 0.49
AG 77 (28.6%) 56 (24.1%)
GG 3 (1.1%) 2 (0.9%)
Allele
A 455 (84.6%) 404 (87.1%) 0.26
G 83 (15.4%) 60 (12.9%)
rs2273346
Genotype
TT 186 (68.4%) 147 (63.4%) 0.19
TC 78 (28.7%) 71 (30.6%)
CC 8 (2.9%) 14 (6.0%)
Allele
T 450 (82.7%) 365 (78.7%) 0.10
C 94 (17.3%) 99 (21.3%)
rs12711521
Genotype
TT 105(38.5%) 106(45.7%) 0.11
TG 137(50.5%) 95(40.9%)
GG 30(11.0%) 31(13.4%)
Allele
T 347 (63.8%) 307(66.2%) 0.43
G 197 (36.2%) 157(33.8%)
rs7548659
Genotype
TT 173 (69.5%) 157 (67.7%) 0.27
TG 61 (24.5%) 67 (28.9%)
GG 15 (6.0%) 8 (3.4%)
Allele
T 407 (81.7%) 381(82.1%) 0.87
G 91 (18.3%) 83(17.9%)
Diplotypea
TT 344(63.2%) 304(65.5%) 0.29
TG 108(19.9%) 60(12.9%)
CT 6(1.1%) 2(0.5%)
CG 86(15.8%) 98(21.1%)
aTwo SNP diplotypes span the genomic region of exon 9 (rs2273346 and rs12711521).BMC Infectious Diseases 2009, 9:51 http://www.biomedcentral.com/1471-2334/9/51
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Table 5: Genotype and allele frequencies of tagSNPs in MASP2 in SARS patients and controls from Guangzhou, northern China, and 
their association with risk of SARS
SARS cases
(n = 104)
Controls
(n = 291)
P value
rs2261695
Genotype
AA 73(75.3%) 193(70.4%) 0.45
AG 22(22.7%) 78(28.5%)
GG 2(2.0%) 3(1.1%)
Allele
A 168(86.6%) 464(84.7%) 0.52
G 26(13.4%) 84(15.3%)
rs2273346
Genotype
TT 64(61.5%) 190(66.2%) 0.48
TC 36(34.6%) 82(28.6%)
CC 4(3.8%) 15(5.2%)
Allele
T 164(78.8%) 462(80.5%) 0.61
C 44(21.2%) 112(19.5%)
rs12711521
Genotype
TT 58(55.8%) 139(47.8%) 0.25
TG 36(34.6%) 108(37.1%)
GG 10(9.6%) 44(15.1%)
Allele
T 152(73.1%) 386(66.3%) 0.07
G 56(26.9%) 196(33.7%)
rs7548659
Genotype
TT 70(67.3%) 205(70.5%) 0.15
TG 25(24.0%) 75(27.8%)
GG 9(8.7%) 11(1.7%)
Allele
T 165(79.3%) 485(83.3%) 0.19
G 43(20.7%) 97(16.7%)
Diplotypea
TT 128(61.5%) 380(65.3%) 0.66
TG 42(20.2%) 76(13.0%)
CT 4(1.9%) 4(0.7%)
CG 34(16.4%) 122(21.0%)
aTwo SNP diplotypes span the genomic region of exon 9 (rs2273346 and rs12711521).BMC Infectious Diseases 2009, 9:51 http://www.biomedcentral.com/1471-2334/9/51
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Table 6: The joined analysis of the Beijing and Guangzhou population
SARS cases controls
Genotype P1 P2 C1 C2 P1 vs.P2 C1vs.C2 P1, P2 vs. C1, C2
(n = 272) (n = 104) (n = 232) (n = 291) P P P
rs2261695
AA 189 (70.3%) 73
(75.3%)
174 (75.0%) 193
(70.4%)
0.35 0.25 0.76
AG 77
(28.6%)
22
(22.7%)
56
(24.1%)
78
(28.5%)
GG 3
(1.1%)
2
(2.0%)
2
(0.9%)
3
(1.1%)
rs2273346
TT 186 (68.4%) 64
(61.5%)
147
(63.4%)
190
(66.2%)
0.21 0.50 0.63
TC 78 (28.7%) 36
(34.6%)
71
(30.6%)
82
(28.6%)
CC 8
(2.9%)
4
(3.8%)
14
(6%)
15
(5.2%)
rs12711521
TT 105
(38.5%)
58
(55.8%)
106
(45.7%)
139
(47.8%)
0.003 0.64 0.30
TG 137
(50.5%)
36
(34.6%)
95
(40.9%)
108
(37.1%)
GG 30
(11.0%)
10
(9.6%)
31
(13.4%)
44
(15.1%)
rs7548659
TT 173
(69.5%)
70
(67.3%)
157
(67.7%)
205
(70.5%)
0.69 0.50 0.91
TG 61 (24.5%) 25
(24.0%)
67
(28.9%)
75
(27.8%)
GG 15
(6.0%)
9
(8.7%)
8
(3.4%)
11
(1.7%)
Diplotypea
TT 344
(63.2%)
128
(61.5%)
304
(65.5%)
380
(65.3%)
0.89 1.00 0.31
TG 108
(19.9%)
42
(20.2%)
60
(12.9%)
76
(13.0%)
CT 6
(1.1%)
4
(1.9%)
2
(0.5%)
4
(0.7%)
CG 86
(15.8%)
34
(16.4%)
98
(21.1%)
122
(21.0%)
P1:SARS patients from Beijing; P2: SARS patients from Guangzhou; C1:controls from Beijing; C2:controls from Guangzhou.BMC Infectious Diseases 2009, 9:51 http://www.biomedcentral.com/1471-2334/9/51
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